Philip J. Barter
The Heart Research Institute
7 Eliza Street
Newtown
Sydney
Australia
Name/email consistency: high
- Raising HDL-C can be achieved by both lifestyle changes and pharmacological means. Introduction. Barter, P. Atheroscler. Suppl (2011)
- Effect of Torcetrapib on Glucose, Insulin, and Hemoglobin A1c in Subjects in the Investigation of Lipid Level Management to Understand its Impact in Atherosclerotic Events (ILLUMINATE) Trial. Barter, P.J., Rye, K.A., Tardif, J.C., Waters, D.D., Boekholdt, S.M., Breazna, A., Kastelein, J.J. Circulation (2011)
- Effect of statins on HDL-C: a complex process unrelated to changes in LDL-C: analysis of the VOYAGER Database. Barter, P.J., Brandrup-Wognsen, G., Palmer, M.K., Nicholls, S.J. J. Lipid Res. (2010)
- Lessons learned from the Investigation of Lipid Level Management to Understand its Impact in Atherosclerotic Events (ILLUMINATE) trial. Barter, P. Am. J. Cardiol. (2009)
- Is there a role for fibrates in the management of dyslipidemia in the metabolic syndrome? Barter, P.J., Rye, K.A. Arterioscler. Thromb. Vasc. Biol. (2008)
- Serum insulin and inflammatory markers in overweight individuals with and without dyslipidemia. Barter, P., McPherson, Y.R., Song, K., Kesäniemi, Y.A., Mahley, R., Waeber, G., Bersot, T., Mooser, V., Waterworth, D., Grundy, S.M. J. Clin. Endocrinol. Metab. (2007)
- New insights into the role of HDL as an anti-inflammatory agent in the prevention of cardiovascular disease. Barter, P.J., Puranik, R., Rye, K.A. Curr. Cardiol. Rep (2007)
- Effects of torcetrapib in patients at high risk for coronary events. Barter, P.J., Caulfield, M., Eriksson, M., Grundy, S.M., Kastelein, J.J., Komajda, M., Lopez-Sendon, J., Mosca, L., Tardif, J.C., Waters, D.D., Shear, C.L., Revkin, J.H., Buhr, K.A., Fisher, M.R., Tall, A.R., Brewer, B. N. Engl. J. Med. (2007)
- HDL cholesterol, very low levels of LDL cholesterol, and cardiovascular events. Barter, P., Gotto, A.M., LaRosa, J.C., Maroni, J., Szarek, M., Grundy, S.M., Kastelein, J.J., Bittner, V., Fruchart, J.C. N. Engl. J. Med. (2007)
- Aggressive management of obesity in children and young adults: the known challenges and potential opportunities. Barter, P.J., Shear, C.L. Clin. Pharmacol. Ther. (2007)
- The rationale for using apoA-I as a clinical marker of cardiovascular risk. Barter, P.J., Rye, K.A. J. Intern. Med. (2006)
- Are we lowering LDL cholesterol sufficiently?. Barter, P., Rye, K.A. Nature Clinical Practice. Cardiovascular Medicine (2006)
- Relationship between the concentration and antiatherogenic activity of high-density lipoproteins. Barter, P.J., Rye, K.A. Curr. Opin. Lipidol. (2006)
- Is it appropriate to make statins available over the counter? The argument against the appropriateness of over-the-counter statins. Barter, P.J., Rye, K.A. Circulation (2006)
